At its 18 September online CRT meeting, Alzheimer Europe welcomed industry representatives from Acument, Alzheon, Bioacrtic, Biogen, Bristol Meyers Squibb, C2N Diagnostics, Eisai, Eli Lilly, MSD, NovoNordisk, TauRX and Terumbo BCT along with AE staff and the chairs of both the EWGPWD and EDCWG.
Cindy Birck began with an update on the Clinical trial watch, a dementia-friendly online resource. She spoke about the 20 active phase II trials, 13 phase III trials in the CRT, plus 4 new studies, all of which are happening in at least one EU country. She then shared about the upcoming CRT supplement which will accompany the October newsletter.
Angela Bradshaw then presented the regulatory developments in anti-amyloid treatments, discussing the EMA and MHRA decisions and shared AE's three priorities for the the new position paper being drafted for EMA/CHMP. She also shared highlights from the Academy meeting on 17 September where issues surrounding anti-amyloid treatments were discussed.
Jean Georges provided an update on Alzheimer Europe activities, projects and staffing changes, sharing the list of current research projects including new projects launched in 2024 AD-RIDDLE and AI4Hope as well as three new projects beginning in in 2025 - DORIAN GRAY, FluiDx-AD and PREDICTFTD. Jean Georges then continued with an overview of the 2025 Work Plan and AE's core activities, finishing off by presenting AE's sponsorship opportunities and corporate activities.
Owen Miller was up next to share EU policy developments and an overview of AE’s European Parliament election campaign and its key components: the Helsinki Manifesto, 2024 Call to Action, and the European Dementia Pledge, going on to share the re-establishment of the European Alzheimer's Alliance (EAA) which will launch on World Alzheimer Day on 21 September.
Ana Diaz then presented AE's work in public involvement in research and the opportunities for companies to work with the Public involvement pool that has been created. She explained the benefits of involving people with dementia and their caregivers in research and the role of the working groups in research. The meeting was moderated by Jean Georges, who thanked everyone for their contributions.
